| Total | Colonised | Aspergillosis | ||
---|---|---|---|---|---|
 |  |  | Probable | Proven | Probable + Proven |
No. patients | 245 | 106 | 125 | 14 | 139 |
Steroids intake before admission | 101 (41.2) | 29 (27.4) | 64 (51.2)a | 8 (57.1)a | 72 (51.8)a |
 ≥20 mg/day | 59 (58.4) | 15 (51.7) | 40 (62.5) | 4 (50.0) | 44 (61.1) |
 Accumulated dose >100 mg | 76 (75.2) | 17 (58.6) | 52 (81.3)a | 7 (87.5) | 59 (81.9)a |
 Accumulated dose >700 mg | 20 (19.8) | 6 (20.7) | 11 (17.2) | 3 (37.5) | 14 (19.4) |
Antibiotic treatment before admission | 88 (35.9) | 34 (32.1) | 47 (37.6) | 7 (50.0) | 54 (38.8) |
Antifungal treatment after culture request | 141 (57.6) | 31 (29.2) | 96 (76.8)a | 14 (100)a | 110 (79.1)a |
 Voriconazole as monotherapy | 68 (48.2) | 11 (35.5) | 55 (57.3) | 2 (14.3) | 57 (51.8) |
 Voriconazole + other antifungals | 30 (21.3) | 5 (16.1) | 18 (18.8) | 7 (50.0) | 25 (22.7) |
 Total patients receiving voriconazole | 98 (69.5) | 16 (51.6) | 73 (76.1) | 9 (64.3) | 82 (74.5) |
 Other antifungals | 43 (30.5) | 15 (48.4) | 23 (24.0) | 5 (35.7) | 28 (25.5) |